C71T
CANCELLED SECTION 71
05/08/2026
Back to search
Official data from USPTO
URSAPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
URSAPHARM
ST13
US500000079233719Class
5, 10, 35
Filing
79233719
Registration
5887500
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
06/02/2026
Trademark type
Word
Nice classes
5, 10, 35
Filing date
02/23/2018
Registration date
10/22/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/08/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
SaarbrÜcken, DE
Examiner
MICHELI, ANGELA M
Law office
L10
Current location
TMEG LAW OFFICE 101
Holders and representatives
Holders
URSAPHARM Arzneimittel GmbH
URSAPHARM Arzneimittel GmbH
Representatives
Ellen A. Rubel MOORE & VAN ALLEN PLLC
Technical classification
Nice Classes
Class 5Class 10Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products and preparationsophthalmologic preparations and eye dropseye ointmentseye compressesmedicated compressesmedicated creams for skin care and for treating dermatological conditionsnasal ointmentsallergy relief medicationaerosol dispensers for medical use sold filled with allergy medicationsnasal spray preparationssaline solutions for medical purposesconcentrated saline capsules for sinus and nasal irrigationcough treatment preparationscough syrupscough dropscough and cold remedies; pharmaceutical and medical preparations for ophthalmological use and to reduce swelling; Pharmaceuticalmedical and veterinary preparations for the treatment of ophthalmologicalnasalallergic and gastrointestinal conditionsdiseases and disorders; Dietetic food and supplements in the nature of capsulessyrupsdropsgranulate adapted for medical use; Dietary supplements for humans and animals
Class 10
Containers with dosing devices for dispensing pharmaceuticalsdosing containers for eye dropssold empty; surgical and medical apparatus and instrumentschemically activated hot compresses
Class 35
Wholesale and retail storeonline retail and wholesale store services featuring pharmaceuticalsmedical and veterinary preparationssanitary preparations for medical purposesdietetic food and substances adapted for medical or veterinary usefood for babiesdietary supplements for humans and animalsplastersmaterials for dressingsmaterials for stopping teethdental waxdisinfectantspreparations for destroying verminfungicidesherbicidescontainers with dosing devicesin particular for dispensing pharmaceutical products
Publications
History of USPTO decisions and trademark events.
41 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/08/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/22/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
09/23/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2020
WDRL
OTQR WITHDRAWAL FROM PUBLICATION
09/02/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/27/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/30/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/28/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/10/2020
FIMP
FINAL DISPOSITION PROCESSED
02/10/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/23/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/22/2020
ES7R
TEAS SECTION 7 REQUEST RECEIVED
12/11/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2019
PUBO
PUBLISHED FOR OPPOSITION
08/06/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/02/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/17/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/17/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/28/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/27/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/27/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/22/2019
GNFR
FINAL REFUSAL E-MAILED
01/22/2019
CNFR
FINAL REFUSAL WRITTEN
01/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2018
ALIE
ASSIGNED TO LIE
12/22/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2018
RFNT
REFUSAL PROCESSED BY IB
07/07/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/21/2018
RFRR
REFUSAL PROCESSED BY MPU
06/21/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/14/2018
CNRT
NON-FINAL ACTION WRITTEN
06/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
06/12/2018
DOCK
ASSIGNED TO EXAMINER
06/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/07/2018
Continuous trademark protection
Get notified about every new filing that threatens URSAPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.